Arrowpoint Investment Partners »

Mineralys Therapeutics shares owned by Arrowpoint Investment Partners

Quarter-by-quarter ownership of Mineralys Therapeutics (MLYS) shares owned by Arrowpoint Investment Partners from 13F filings

Historical chart of Arrowpoint Investment Partners investment in Mineralys Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mineralys Therapeutics held by Arrowpoint Investment Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mineralys Therapeutics by Arrowpoint Investment Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $232k 6.4k 36.29

More positions owned by Arrowpoint Investment Partners

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Johnson & Johnson (JNJ)
Citigroup Com New (C)
Home Depot (HD)
Qualcomm (QCOM)
Palantir Technologies Cl A (PLTR)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Amazon (AMZN)
Apple (AAPL)
Aegon Amer Reg 1 Cert (AEG)
Tesla Motors (TSLA)
Paypal Holdings (PYPL)
Invesco Exch Traded Fd Tr Ii Sr Ln Etf (BKLN)
Eli Lilly & Co. (LLY)

View all positions for Arrowpoint Investment Partners

Top funds holding Mineralys Therapeutics

Catalys Pacific
RA Capital Management
Samsara BioCapital
Caligan Partners
BlackRock
Vanguard Group
State Street Corporation
Caption Management
Citadel Advisors
FMR
Franklin Resources
Laurion Capital Management
Boothbay Fund Management
Holocene Advisors
Sr One Capital Management

View all funds holding Mineralys Therapeutics